SCHEMBL3560669

SCHEMBL3560669

O=C(O)c1ccc(CCc2ccc(NS(=O)(=O)C=Cc3ccccc3)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.84
PKM P14618 1/20 0.58
ALDH1A1 P00352 5/20 0.56
POLB P06746 3/20 0.56
GAA P10253 3/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
LMNA P02545 3/20 0.56
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
NPC1 O15118 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
HTT P42858 1/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
PTGES2 Q9H7Z7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3560667 1.00 KMT2A (0.84) KMT2APKMALDH1A1POLBGAA
SCHEMBL7813542 0.92 KMT2A (1.00) KMT2APKMALDH1A1POLBGAA
SCHEMBL7813544 0.92 KMT2A (1.00) KMT2APKMALDH1A1POLBGAA
SCHEMBL3552428 0.89 KMT2A (0.67) KMT2APKMALDH1A1POLBGAA
SCHEMBL3559358 0.89 KMT2A (0.67) KMT2APKMALDH1A1POLBGAA
SCHEMBL3559362 0.89 KMT2A (0.67) KMT2APKMALDH1A1POLBGAA
SCHEMBL3552430 0.89 KMT2A (0.67) KMT2APKMALDH1A1POLBGAA
SCHEMBL3558757 0.85 KMT2A (0.61) KMT2APKMALDH1A1POLBGAA
SCHEMBL3555163 0.85 KMT2A (0.61) KMT2APKMALDH1A1POLBGAA
SCHEMBL3558754 0.85 KMT2A (0.61) KMT2APKMALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 KMT2A 4045/4885PKM 990/4885ALDH1A1 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.